NCT00032721

Brief Summary

This study will investigate the use of Reiki, an energy-based complementary and alternative medicine (CAM) intervention, as an approach to improve well-being for patients with advanced AIDS, and evaluate its effects on dimensions of well-being and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2002

Shorter than P25 for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2002

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 29, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 1, 2002

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2003

Completed
Last Updated

August 18, 2006

Status Verified

July 1, 2006

First QC Date

March 29, 2002

Last Update Submit

August 17, 2006

Conditions

Acquired Immunodeficiency SyndromeHIV Infections

Keywords

complementary therapiesAlternative medicineComplementary and alternative medicineSubtle energy therapyReikiHIV/AIDS

Interventions

Reiki; Subtle energy therapyPROCEDURE

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of advanced AIDS, defined as: CD4 count of less than 200 during the past 12 months;
  • On HAART for at least 6 months;
  • Over age 18;
  • Decisionally capable of providing informed consent.

You may not qualify if:

  • Not capable of providing informed consent because of psychiatric limitations, e.g. active psychosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Temple University

Philadelphia, Pennsylvania, 19121, United States

Location

Albert Einstein Medical Center

Philadelphia, Pennsylvania, 19141, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV Infections

Interventions

Therapeutic Touch

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual Therapies

Study Officials

  • Gala True, PhD

    Albert Einstein Healthcare Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
NIH

Study Record Dates

First Submitted

March 29, 2002

First Posted

April 1, 2002

Study Start

March 1, 2002

Study Completion

September 1, 2003

Last Updated

August 18, 2006

Record last verified: 2006-07

Locations

US(2)